A Manchester-headquartered MedTech company listed on the London Stock Exchange’s AIM market is set to be acquired for £16.7 million. The board of Yourgene has recommended that shareholders accept an offer from Novacyt UK which represents a premium of approximately 167.7% to its closing share price on Friday. Yourgene, which also has bases in Taipei, … Continue reading £16.7m deal agreed for Manchester MedTech Yourgene